Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Oct 15, 2006 (Vol. 26, No. 18)

ProSplicer

URL:prosplicer.mbc.nctu.edu.tw
  • Easy access to analyses
  • A bit narrowly focused
Alternative splicing is an important topic, what with the discovery of considerably fewer genes in the human genome than expected. What we lack in raw numbers, we make up for by mixing and matching sequences, and that is where ProSplicer comes in. Providing an alternative splicing database, based on protein, mRNA, and EST sequences, ProSplicer offers several useful search tools to the user. They include searches for gene names and gene sequences using several naming formats (gene searches) and options for searching protein or DNA sequences of genes. An excellent online paper about ProSplicer informs users of the technical considerations built into the site. This is an essential site for anyone interested in gene expression in eukaryotes.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »